 Tuberculosis | | FDA/AUA Panel NMIBC Are the current data that we have regarding BCG efficacy of good enough quality to establish a non‐ inferiority margin for trials today? Seth P. Lerner, MD, FACSAdd to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 217,77 KBShare Document on Facebook
|